TerrAscend (TSNDF) Enterprise Value (2020 - 2026)
TerrAscend's (TSNDF) quarterly Enterprise Value came in at $2.5 million in Q1 2026, up 108.53% year-on-year from $1.2 million in Q1 2025, and up 138.91% on a QoQ basis from $1.1 million in Q4 2025.
TerrAscend (TSNDF) Enterprise Value (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 7 years of Enterprise Value data on file, last reported at $2.5 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 108.53% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 108.53% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 142.96% from the prior year.
- Enterprise Value for Q1 2026 stood at $2.5 million, up from $1.1 million in the prior quarter.
- Over the last five years, Enterprise Value for TSNDF reached as high as $2.5 million in Q1 2026 and fell as low as -$87.0 million in Q1 2022.
- Historically, Enterprise Value has averaged -$19.3 million across 5 years, with a median of -$25.9 million in 2023.
- Across the five-year window, Enterprise Value slumped 8259.09% in 2024 and soared 142.96% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$27.4 million in 2022, then climbed by 5.37% to -$25.9 million in 2023, then soared by 90.44% to -$2.5 million in 2024, then jumped by 142.96% to $1.1 million in 2025, then jumped by 138.91% to $2.5 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were $2.5 million in Q1 2026, $1.1 million in Q4 2025, and -$35.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 2.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.54 Mn |
| Dec 31, 2025 | 1.06 Mn |
| Sep 30, 2025 | -35.89 Mn |
| Jun 30, 2025 | -27.22 Mn |
| Mar 31, 2025 | -29.81 Mn |
| Dec 31, 2024 | -2.48 Mn |
| Sep 30, 2024 | -27.33 Mn |
| Jun 30, 2024 | -3.37 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Dec 31, 2023 | -25.91 Mn |
| Sep 30, 2023 | -1.95 Mn |
| Jun 30, 2023 | -28.88 Mn |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | -27.38 Mn |
| Sep 30, 2022 | -32.68 Mn |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | -87.04 Mn |
| Dec 31, 2021 | -74.28 Mn |
| Dec 31, 2020 | 3.80 Mn |